Tekrolab

Tekrolab is a specialized contract research and development project within TEKRO, a leading veterinary and pharmaceutical company. We focus on delivering high-quality preclinical services in compliance with Good Laboratory Practice (GLP), supporting both the veterinary and human pharmaceutical industries. Our expertise spans pharmacokinetic (PK) studies, residue analyses, and controlled-release drug delivery research, with a strong foundation in swine models. With years of experience in veterinary medicine, animal nutrition, and pharmaceutical manufacturing, Tekrolab combines scientific excellence with practical know-how. We offer tailored study designs that meet strict regulatory requirements, including EMA guidelines, ensuring reliable and submission-ready data. Our dedicated team is committed to advancing drug development pipelines, from early research through regulatory approval. Our services cover a wide spectrum — from pharmacokinetic profiling and tissue distribution studies, to residue depletion testing in target organs such as joints and kidneys. We also work with innovative drug carriers and controlled release systems, helping clients assess efficacy and safety in real-world applications. This makes Tekrolab a trusted partner for companies seeking robust and regulatory-compliant preclinical research. In addition to CRO activities, Tekrolab acts as a Contract Development and Manufacturing Organization (CDMO), providing flexible production of veterinary medicinal products (non-sterile powder forms, tablets.), feed additives and feed. We offer a unique integrated platform for clients in animal health.